MARFELLA, RAFFAELE
 Distribuzione geografica
Continente #
NA - Nord America 63
EU - Europa 47
AS - Asia 7
Totale 117
Nazione #
US - Stati Uniti d'America 63
IE - Irlanda 22
UA - Ucraina 8
FI - Finlandia 7
SG - Singapore 5
IT - Italia 4
DE - Germania 3
CN - Cina 2
PL - Polonia 1
PT - Portogallo 1
SE - Svezia 1
Totale 117
Città #
Dublin 22
Jacksonville 10
New York 8
Chandler 7
Helsinki 5
Wilmington 3
Frankfurt am Main 2
Lappeenranta 2
Molise 2
Princeton 2
San Mateo 2
West Jordan 2
Huntsville 1
Jinan 1
Lanzhou 1
Lisbon 1
Los Angeles 1
Norwalk 1
San Francisco 1
Totale 74
Nome #
ELectrophysiological mechanisms underlying the Inhibitory CArdiac syncope without asystolic significant pause: Therapeutic and prognostic implications. The ELICA randomized trial 49
Aspirin in a diabetic retinopathy setting: Insights from NO BLIND study 34
Sodium-Glucose Co-Transporters Family: Current Evidence, Clinical Applications and Perspectives 6
Exosomal miR-145 and miR-885 Regulate Thrombosis in COVID-19 6
Inflammatory Cytokines and SIRT1 Levels in Subcutaneous Abdominal Fat: Relationship With Cardiac Performance in Overweight Pre-diabetics Patients 4
Patients with adrenal insufficiency have cardiovascular features associated with hypovolemia 3
Advances in Pharmacological Approaches for Managing Hypercholesterolemia: A Comprehensive Overview of Novel Treatments 3
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study 3
Thrombus aspiration in hyperglycemic ST-elevation myocardial infarction (STEMI) patients: clinical outcomes at 1-year follow-up 3
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 3
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors 2
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease 2
Metformin Lactic Acidosis: should we still be afraid? 2
GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives 1
HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis 1
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 1
Predictive Value of Fatty Liver Index for Long-Term Cardiovascular Events in Patients Receiving Liver Transplantation: The COLT Study 1
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 1
Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma 1
Cardiovascular benefits from gliflozins: Effects on endothelial function 1
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial 1
Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations 1
Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes 1
Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination 1
Totale 131
Categoria #
all - tutte 2.212
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.212


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206 0 0 2 0 1 0 1 0 1 0 0 1
2020/202113 0 1 1 2 4 0 2 0 1 0 2 0
2021/202210 0 2 0 0 0 0 2 1 1 2 0 2
2022/202347 5 1 0 3 2 2 0 3 25 1 5 0
2023/202447 3 2 2 2 4 15 3 7 1 5 3 0
Totale 131